Wednesday broker round-up
(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.
Read more(Sharecast News) - Polypipe: Deutsche Bank upgrades to buy with a target price of 550p.
Read moreLONDON MARKET MIDDAY: Stocks Soaked In Red; Pound Drops Below USD1.20
Read moreMarch 18 (Reuters) - The European Union's healthcare regulator on Wednesday said there currently is no evidence which links anti-inflammatory medicines such as ibuprofen with the worsening of COVID-19.The European Medicines Agency (EMA) said https...
Read moreUK BROKER RATINGS SUMMARY: Jefferies And Exane BNP Both Raise Reckitt
Read moreLONDON BRIEFING: Caterers Suffer From Virus Alongside Travel Industry
Read more(Sharecast News) - Ti Fluid Systems: Citigroup downgrades to neutral with a target price of 140p.
Read moreUK WINNERS & LOSERS SUMMARY: Dixons Carphone Rises On Turnaround Steps
Read moreUK BROKER RATINGS SUMMARY: Goldman Sachs Raises Pearson And Informa
Read more(Adds details, background)March 16 (Reuters) - Nurofen producer Reckitt Benckiser sought to quash warnings against taking the drug on Monday, saying it was not aware of any evidence that the pills' active ingredient ibuprofen adversely impacted pa...
Read more(Adds graphic)By Siddharth Cavale and Richa NaiduMarch 13 (Reuters) - As global makers of household cleaners race to pitch their products as coronavirus killers, one major company, Reckitt Benckiser, may have a leg up on the competition.The maker ...
Read moreBy Siddharth Cavale and Richa NaiduMarch 13 (Reuters) - As global makers of household cleaners race to pitch their products as coronavirus killers, one major company, Reckitt Benckiser, may have a leg up on the competition.The maker of Lysol and D...
Read moreDIRECTOR DEALINGS: Reckitt Executive Sehgal Buys GBP558,000 In Shares
Read more(Sharecast News) - Clinigen Group: Liberum upgrades to buy with a target price of 780.0p.
Read moreDIRECTOR DEALINGS SUMMARY: Reckitt Operations Chief Spends GBP480,000
Read moreUK BROKER RATINGS SUMMARY: Bernstein Upgrades BAT To Outperform
Read more